| Date Filed | Type | Description |
| 03/25/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/17/2021 |
SC 13D/A
| Boundless Meadow Ltd reports a 0% stake in Viela Bio, Inc. |
| 03/15/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/15/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/15/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 03/15/2021 |
8-K
| Quarterly results |
| 03/15/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/15/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/15/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/12/2021 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
| 03/12/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/12/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/08/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/04/2021 |
8-K
| Quarterly results |
| 03/03/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/03/2021 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 03/03/2021 |
CORRESP
| Form CORRESP - Correspondence: |
| 03/03/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/01/2021 |
GN
| SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate WIFI, CHNG, CUB, VIE; Shareholders Are Encouraged to Contact the Firm |
| 03/01/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/01/2021 |
8-K
| Quarterly results |
| 03/01/2021 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 03/01/2021 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 02/26/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/25/2021 |
GN
| Viela Bio Announces Additional Positive Results with UPLIZNA® (inebilizumab-cdon) in Patients with Neuromyelitis Optica Spectrum Disorder at the ACTRIMS 2021 Forum |
| 02/24/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/24/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/19/2021 |
GN
| SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of VIE, FFG, JWS, and RNET Mergers |
| 02/17/2021 |
GN
| INVESTIGATION ALERT: Halper Sadeh LLP Investigates COHR, PRSP, VIE, SPWH; Shareholders Are Encouraged to Contact the Firm |
| 02/16/2021 |
SC 13G/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 4.3% stake in Viela Bio, Inc. |
| 02/16/2021 |
8-K
| Quarterly results |
| 02/12/2021 |
GN
| SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of VIE, FFG, COHR, and CMD Buyouts |
| 02/12/2021 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
|